Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1099/week)
Manufacturing
(549/week)
Technology
(1021/week)
Energy
(410/week)
Other Energy
(252/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Hepatitis
Aug 13, 2020
Global Market and Forecast Model for Hepatitis C Tests Market 2020 with Coverage of 39 Countries
Aug 13, 2020
Global Hepatitis B Tests Industry 2015-2030: COVID-19 Impact, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by Segment
Aug 12, 2020
Akero Therapeutics Reports Second Quarter 2020 Financial Results
Jun 17, 2020
ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial
Jun 17, 2020
Akero Therapeutics Doses First Patient in Expansion of Phase 2a Trial in NASH
Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
Jun 15, 2020
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
Jun 10, 2020
MYR Pharmaceuticals has incorporated its first European subsidiary in France
May 29, 2020
MYR Pharmaceuticals receives positive CHMP opinion for HEPCLUDEX® (bulevirtide), the First-in-Class Entry Inhibitor for the treatment of chronic hepatitis D infections
May 28, 2020
DURECT to Present at the Jefferies 2020 Virtual Health Care Conference
May 26, 2020
Akero Therapeutics To Present At The Jefferies Virtual Healthcare Conference
May 24, 2020
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
May 11, 2020
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
Mar 31, 2020
All AKR-001 Dose Groups Met Week 12 Efficacy Endpoints in NASH Phase 2a BALANCED Study
Mar 31, 2020
Data on Sagimet's Lead Candidate TVB-2640 to be Presented at EASL ILC 2020
Mar 31, 2020
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
Mar 24, 2020
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
Mar 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Mar 16, 2020
Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Page 1
››
Latest News
Jun 22, 2025
Iran says targeted Ben Gurion airport, other sites in attack on Israel
Jun 22, 2025
Japan spots Chinese ships near disputed isles for record 216 straight days
Jun 22, 2025
Israel closes airspace after US strikes on Iran: Israel Airports Authority
Jun 22, 2025
Bourget: le décollage tardif du drone européen
Jun 22, 2025
Trump, Munir exchange praises as Pakistan rises as regional stabilizer: IRS Analysis
Jun 21, 2025
WhiteHawk Completes Tender Offer for Acquisition of PHX
Jun 21, 2025
Gensource Potash Announces Extension to the Maturity Date of Convertible Debentures
Jun 21, 2025
Halliburton Second Quarter 2025 Earnings Conference Call
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events